Found 6 matching trials
Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.
PHASE1Phase Ib, single centre, double-blind, double-dummy placebo-controlled, ran...
Location
Hospital Universitario "Dr. José Eleuterio González" de la Universidad Autónoma de Nuevo León.
Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
PHASE1Double blinded, randomized, placebo-controlled, dose finding, multi-center,...
Location
Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology
Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants
PHASE1The purpose of this study is to describe the safety, tolerability and immun...
Location
Clinical Research of South Florida
A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
PHASE2This clinical study will evaluate the safety, tolerability, and reactogenic...
Location
Meridian Clinical Research (Sioux City, IA)
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
PHASE1This phase 1 clinical trial consists of an initial open-label sentinel run-...
Location
Flourish Research
Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)
PHASE1This study is designed to investigate, at first, safety and tolerability of...
Location
Institute of Specific Prophylaxis and Tropical Medicine